ImageneBio (IMA) Change in Account Payables (2020 - 2025)

ImageneBio has disclosed Change in Account Payables across 6 years of filings, most recently posting -$1.8 million for Q3 2025.

• Change in Account Payables for Q3 2025 came in at -$1.8 million, down 13.69% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.1 million (up 73.0% YoY), and the FY2024 annual result was -$1.2 million, up 59.27% from the prior year.
• Change in Account Payables came in at -$1.8 million for Q3 2025 at ImageneBio, up from -$1.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.4 million in Q1 2025 to a low of -$1.9 million in Q4 2023.
• The 5-year median for Change in Account Payables is -$157000.0 (2024), against an average of -$323578.9.
• Peak annual rise in Change in Account Payables reached 16550.0% in 2023, while the deepest fall reached 2115.29% in 2023.
• ImageneBio's Change in Account Payables stood at $455000.0 in 2021, then plunged by 118.68% to -$85000.0 in 2022, then slumped by 2115.29% to -$1.9 million in 2023, then jumped by 156.66% to $1.1 million in 2024, then tumbled by 268.13% to -$1.8 million in 2025.
• The last three Change in Account Payables figures came in at -$1.8 million (Q3 2025), -$1.8 million (Q2 2025), and $1.4 million (Q1 2025), per Business Quant data.